Mark Kudolo
Impact in
-
- Computational Drug Discovery Methods
-
- Synthesis and biological activity
- Click Chemistry and Applications
Papers in
-
- Melanoma and MAPK Pathways 9
- Protein Kinase Regulation and GTPase Signaling 5
- DNA Repair Mechanisms 2
-
- Synthesis and biological activity 5
- Synthesis of Tetrazole Derivatives 4
- Co-authors
- Stefan Laufer (19 shared papers)Tatu Pantsar (7 shared papers)Michael Förster (7 shared papers)Stefan Knapp (8 shared papers)Pierre Koch (6 shared papers)A. Chaikuad (4 shared papers)Lars Zender (4 shared papers)Matthias Gehringer (3 shared papers)
In The Last Decade
Mark Kudolo
19 papers receiving 286 citations
Peers
Comparison fields: 5 of 61
- Computational Theory and Mathematics 62
- Organic Chemistry 100
- Molecular Biology 188
- Oncology 61
- Pharmacology 30
Countries citing papers authored by Mark Kudolo
This map shows the geographic impact of Mark Kudolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kudolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kudolo more than expected).
Fields of papers citing papers by Mark Kudolo
This network shows the impact of papers produced by Mark Kudolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kudolo. The network helps show where Mark Kudolo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kudolo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 29 | |
| 2 | 2019 | 28 | |
| 3 | 2018 | 24 | |
| 4 | 2022 | 22 | |
| 5 | 2022 | 22 | |
| 6 | 2020 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2019 | 19 | |
| 9 | 2019 | 19 | |
| 10 | 2020 | 17 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2017 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 4 | |
| 19 | 2022 | 4 |
About Mark Kudolo
Mark Kudolo is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Computational Theory and Mathematics and Cell Biology, having authored 19 papers that have together received 293 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Synthesis and biological activity (5 papers), Synthesis of Tetrazole Derivatives (4 papers), Computational Drug Discovery Methods (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), DNA Repair Mechanisms (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Computational Theory and Mathematics (62 citations), Organic Chemistry (100 citations), Molecular Biology (188 citations), Oncology (61 citations) and Pharmacology (30 citations). Mark Kudolo has collaborated with scholars based in Germany, Finland and Brazil. Frequent co-authors include Stefan Laufer, Tatu Pantsar, Michael Förster, Stefan Knapp, Pierre Koch, A. Chaikuad, Lars Zender, Matthias Gehringer, Benedict‐Tilman Berger and Ulrich Rothbauer. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Molecules, Nature Communications and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.